|
LACE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.66280031147437E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.87069995447342E-09 |
| Normal-vs-Stage2 |
4.161800E-02 |
| Normal-vs-Stage3 |
3.22408766351145E-13 |
| Normal-vs-Stage4 |
1.63602464908763E-12 |
| Stage1-vs-Stage2 |
8.171700E-02 |
| Stage1-vs-Stage3 |
9.284400E-03 |
| Stage1-vs-Stage4 |
6.06939999999723E-05 |
| Stage2-vs-Stage3 |
3.524800E-03 |
| Stage2-vs-Stage4 |
2.771300E-04 |
| Stage3-vs-Stage4 |
1.402190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.65280036721083E-11 |
| Normal-vs-AfricanAmerican |
5.85140000000095E-05 |
| Normal-vs-Asian |
3.32079996834267E-09 |
| Caucasian-vs-AfricanAmerican |
8.865000E-01 |
| Caucasian-vs-Asian |
2.955800E-01 |
| AfricanAmerican-vs-Asian |
4.200000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.30060001552113E-09 |
| Normal-vs-Female |
1.00370001199224E-09 |
| Male-vs-Female |
6.519600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.90759999965751E-07 |
| Normal-vs-Age(41-60Yrs) |
1.03720032562649E-10 |
| Normal-vs-Age(61-80Yrs) |
7.98029999971028E-07 |
| Normal-vs-Age(81-100Yrs) |
1.940260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.989500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.942000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.609000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.621200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.027000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.411600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.258340E-03 |
| Classical-VS-Follicular |
2.296500E-03 |
| Classical-VS-Other |
6.157800E-01 |
| Classical-VS-Normal |
8.42439451531618E-11 |
| Tall-VS-Follicular |
8.10199999978778E-07 |
| Tall-VS-Other |
3.718400E-01 |
| Tall-VS-Normal |
1.86939352886384E-12 |
| Follicular-VS-Other |
1.709580E-01 |
| Follicular-VS-Normal |
4.459900E-03 |
| Other-VS-Normal |
1.082160E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36859999999572E-08 |
| Normal-vs-N1 |
5.1636472875316E-13 |
| N0-vs-N1 |
1.319750E-03 |
|
|
